Lanzhou Foci Pharmaceutical Co.,Ltd.’s Net Profit Rose 27.3% in First Quarter of 2023

Lanzhou Foci Pharmaceutical Co.,Ltd. (兰州佛慈制药股份有限公司) (002644.SZ) reported a net profit of 27.4 million yuan in the first quarter of 2023, up 27.3% year-on-year.

Meanwhile, the company posted 307.4 million yuan in revenue, up 29.8% year-on-year.

At the end of the reporting period, it had 2.7 billion yuan in total assets and 945.5 million yuan in total liabilities, with a liability-to-asset ratio of 34.9%.